Head of Group Finance
A global biopharmaceutical company is seeking a Head of Group Finance. The selected candidate will oversee group financial reporting, consolidation, tax, treasury, and compliance functions, while driving continuous process improvement and supporting strategic initiatives.
Responsibilities:
- Manage a team of qualified accountants and oversee group-wide financial operations
- Advise entity Heads of Finance on IFRS accounting and lead consolidation processes
- Prepare monthly consolidated internal and external IFRS financial statements and reports
- Lead quarterly forecasting and annual budgeting activities
- Coordinate tax calculations and postings, ensuring compliance with IFRS and local GAAP
- Maintain transfer pricing documentation and manage tax relationships
- Oversee treasury functions, including cash flow forecasting, liquidity, and FX management
- Ensure financial compliance under J-SOX and support statutory audits
- Drive process and system improvements, including IFRS 18 readiness
Requirements:
- More than 5 years of experience in accounting at a listed company in Japan, including management of similar operations
- Proven experience in financial reporting, consolidation, tax, treasury, and compliance
- Possess a valid JCCI Bookkeeping Level 1+
- Proficient in Japanese and English
About the Company:
A leading global innovator in the pharmaceutical industry, this company is dedicated to developing advanced therapies that improve lives and shape the future of healthcare. Known for its cutting-edge research, collaborative culture, and career growth opportunities, it offers an inspiring environment for job seekers passionate about driving medical innovation.
Keywords:
バイオ製薬, 財務管理, 連結決算, 税務, 予算編成, 財務報告, 資金管理, 求人, 外資系
Job Ref: H76IO0
仕事内容
雇用形態 : 正社員
専門分野 : 経理/財務
職種 : 財務分析
業界 : 医薬・製薬
給与 : ¥16,000,000 - ¥19,000,000 per annum
勤務形態: オフィス・現場勤務
職務レベル: 部長・ディレクター
主な使用言語: 日本語 - ビジネスレべル
その他の使用言語: 英語 - ビジネスレべル
勤務地 : Tokyo
FULL_TIME求人番号 : H76IO0-7DA536B4
掲載日 : 2025年11月29日
担当コンサルタント : Asjad Junaid
kanto accountancy-finance/financial-analysis 2025-11-29 2026-01-28 pharmaceuticals Tokyo JP JPY 16000000 19000000 19000000 YEAR Robert Walters https://www.robertwalters.co.jp https://www.robertwalters.co.jp/content/dam/robert-walters/global/images/logos/web-logos/square-logo.png true